Shanghai Pharmaceuticals Holding Co., Ltd. Sponsored ADR (SHPMY)
OTC
Closed
Aug 21, 2026
Day's Range
7.3852 wk Range
7.04Overview - SHPMY - Shanghai Pharmaceuticals Holding Co., Ltd. Sponsored ADR
Key Statistics
Valuation
Enterprise Value
5.55B
P/E (Trailing)
‪6.36‬
PEG Ratio
‪1.14‬
Price / Sales (TTM)
‪0.01‬
Price / Book
‪0.47‬
EV / EBITDA
‪3.43‬
Profitability
Gross Margin
‪10.75%‬
Profit Margin
‪2.01%‬
Operating Margin
‪3.49%‬
Return on Assets
‪2.38%‬
Return on Equity
‪8.12%‬
Ownership
Shares Outstanding
3.70B
Float
301.58M
Price stats
Beta
‪0.15‬
50-Day Avg
‪7.39‬
200-Day Avg
‪7.71‬
Dividends
Payout Ratio
‪26.20%‬
Frequency
Annual
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - SHPMY - Shanghai Pharmaceuticals Holding Co., Ltd. Sponsored ADR
Peers - SHPMY - Shanghai Pharmaceuticals Holding Co., Ltd. Sponsored ADR
Peer Comparison
Compared with companies in Medical Distribution listed on OTC.
Profile Summary - SHPMY - Shanghai Pharmaceuticals Holding Co., Ltd. Sponsored ADR
About
Shanghai Pharmaceuticals Holding Co., Ltd. Sponsored ADR represents American Depositary Receipts for the shares of Shanghai Pharmaceuticals Holding Co. Ltd., a leading company in the pharmaceutical industry based in China. This ADR allows investors in the United States to easily invest in Shanghai Pharmaceuticals…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
